Cost of disease-modifying therapies for multiple sclerosis continues to rise in US
Pharmaceutical Technology
MAY 19, 2023
While MS is not a terminal diagnosis, the effect of the disease on the CNS can significantly impact patients’ independence and disturb their daily lives. DMTs for MS have a high price tag, particularly in the US. However, they cannot provide a cure and have a very limited impact on halting disease progression.
Let's personalize your content